CFTR and cystic fibrosis: The U.S. Food and Drug Administration has approved several CFTR modulators for CF therapy, including TrikaftaTM, Kalydeco®, Orkambi®, and Symdeko® (Vertex Pharmaceuticals Inc., Boston, MA, USA) [17].